feed,title,long_url,short_url
gNews,Neurocrine Biosciences Nose-Dives After Schizophrenia Treatment Lags Its Rivals - Investor's Business Daily,https://news.google.com/rss/articles/CBMiqAFBVV95cUxOSkVnWmhJQ0dSdVNTZ2Z0QlEyaG96OWxHYUpOOHpYaU4tZ29udkZITmdOSlRmWFdMSjFYTkMxcnpySUhVYnJkdDE3eTFkTEN6aEY3TlNveWR0NW54NFI2dFFUM29Bb25ROTl6TE9EUUhSSjRWczBoX2s3aUFMdmhxSzhVaXNScjY2MnVJV1plOEZ1VlVDWS1wRW5TRTlzSVV2VWJKbE1ISC0?oc=5,https://da.gd/F2Yz
